Finance

Lists
TMOS34:BVMF
Thermo Fisher Scientific BDR
R$74.06
0.00%
(0.00) 1D
Oct 15, 4:56:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for TMOS34...
Open
R$71.24
High
R$74.32
Low
R$71.24
Mkt. cap
257.53B
Avg. vol.
10.16K
Volume
239.00
52-wk high
R$74.32
52-wk low
R$45.62
Shares outstanding
369.75M
No. of employees
125K
Open
R$71.24
High
R$74.32
Low
R$71.24
Mkt. cap
257.53B
Avg. vol.
10.16K
Volume
239.00
52-wk high
R$74.32
52-wk low
R$45.62
Shares outstanding
369.75M
No. of employees
125K
News stories
From web sources and news partners
About Thermo Fisher Scientific BDR
CEO-
Employees125K
Founded1956
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websitethermofisher.com
Next call in 5 days
Wed, Oct 21, 1:00 PM
Fiscal period
Q3 2026
- / $6.40
Revenue / Est. (USD)
- / 11.93B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
11.12B
12.22B
11.00B
11.99B
Cost of goods sold
6.53B
7.17B
6.56B
7.08B
Cost of revenue
6.53B
7.17B
6.56B
7.08B
Research and development expenses
346.00M
356.00M
336.00M
364.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.10B
2.24B
2.14B
2.30B
Operating expense
2.45B
2.46B
2.48B
2.66B
Total operating expenses
8.98B
9.63B
9.04B
9.74B
Operating income
2.14B
2.59B
1.97B
2.25B
Other non operating income
-32.00M
-32.00M
-15.00M
13.00M
EBT including unusual items
1.83B
2.12B
1.73B
1.91B
EBT excluding unusual items
2.03B
2.44B
1.83B
2.05B
Income tax expense
207.00M
153.00M
70.00M
167.00M
Effective tax rate
11.32%
7.21%
4.06%
8.75%
Other operating expenses
-
-135.00M
1.00M
-
Net income
1.62B
1.96B
1.65B
1.74B
Net profit margin
14.53%
16.08%
15.00%
14.47%
Earnings per share
5.79
6.57
5.44
6.03
Interest and investment income
234.00M
258.00M
233.00M
207.00M
Interest expense
-347.00M
-365.00M
-354.00M
-401.00M
Net interest expenses
-113.00M
-107.00M
-121.00M
-194.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.82B
3.31B
2.70B
3.07B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps